1-4 of 4
Jennifer Brewin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells

Ida Ricciardelli, Michael Patrick Blundell, Jennifer Brewin, Adrian Thrasher, Martin Pule, Persis J. Amrolia
Journal: Blood
Blood (2014) 124 (16): 2514–2522.
https://doi.org/10.1182/blood-2014-01-553362
Published: 2014
Includes: Supplemental data
Journal Articles

Functional characterization of alloreactive T cells identifies CD25 and CD71 as optimal targets for a clinically applicable allodepletion strategy

Sujith Samarasinghe, Christoph Mancao, Martin Pule, Niga Nawroly, Helen Karlsson, Jennifer Brewin, Peter Openshaw, H. Bobby Gaspar, Paul Veys, Persis J. Amrolia
Journal: Blood
Blood (2010) 115 (2): 396–407.
https://doi.org/10.1182/blood-2009-08-235895
Published: 2010
Includes: Supplemental data
Journal Articles

Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease

Jennifer Brewin, Christoph Mancao, Karin Straathof, Helen Karlsson, Sujith Samarasinghe, Persis J. Amrolia, Martin Pule
Journal: Blood
Blood (2009) 114 (23): 4792–4803.
https://doi.org/10.1182/blood-2009-07-228387
Published: 2009
Includes: Supplemental data
Journal Articles

A Novel Strategy to Render CTL Resistant to Immunosuppression with Calcineurin Inhibitors

Jennifer Brewin, Karin Straathof, Helen Karlsson, Cristoph Mancao, Barbara Savoldo, Gianpietro Dotti, Martin Pule, Persis Amrolia
Journal: Blood
Blood (2008) 112 (11): 3897.
https://doi.org/10.1182/blood.V112.11.3897.3897
Published: 2008